Security key
74587V107
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)
CUSIP: 74587V107
Q4 2013 13F Holders as of 31 Dec 2013
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,633,071
- Total 13F shares
- 24,039,860
- Share change
- +416,964
- Total reported value
- $2,488,843,397
- Put/Call ratio
- 86%
- Price per share
- $103.53
- Number of holders
- 113
- Value change
- +$43,662,335
- Number of buys
- 1
- Number of sells
- 2
Report period
Q4 2013
Institutions
113
Top holders
10
PBYI full security history
Newer quarter: Q1 2014
Previous quarter: Q3 2013
PUMA BIOTECHNOLOGY, INC. SEC filings
PUMA BIOTECHNOLOGY, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74587V107
Recent filing periods:
Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.64%
|
319,683
|
$17,154,000 | — | 30 Sep 2013 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.37%
|
183,674
|
$9,856,000 | — | 30 Sep 2013 | |
| PDT Partners, LLC |
13F
|
Company |
0.02%
|
9,924
|
$533,000 | — | 30 Sep 2013 |
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2013
As of 31 Dec 2013,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,039,860 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, LORD, ABBETT & CO. LLC, VANGUARD GROUP INC, Citadel Advisors LLC, FRANKLIN RESOURCES INC, BlackRock Fund Advisors, State Street Corp, and FEDERATED INVESTORS INC /PA/.
This page lists
113
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2013 vs Q3 2013 Across Filers
Q3 2013 holders
3
Q4 2013 holders
113
Holder diff
110
| Investor | Q3 2013 Shares | Q4 2013 Shares | Share Diff | Share Chg % | Q3 2013 Value $ | Q4 2013 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.